Article

Prediction of mild cognitive impairment progression using time-sensitive multimodal biomarkers

2025-09-22

Abstract excerpt

Alzheimer’s disease (AD) develops over a prolonged asymptomatic phase marked by silent pathology. Identifying cognitively unimpaired individuals likely to progress to mild cognitive impairment (MCI) is essential for early intervention. We investigated whether multimodal combinations of biomarkers, including frequency-specific neurophysiological activity, enhance prediction beyond demographic and genetic factors in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a172ac76-9104-5ac5-ae2f-8ea768627000
DOI: 10.1101/2025.09.20.25336240

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prediction of mild cognitive impairment progression using time-sensitive multimodal biomarkersDOI 10.1101/2025.09.20.25336240Read

Revealing the combined roles of Aβ and tau in Alzheimer’s disease via a pathophysiological activity decoderSemantic proximity Read

Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measuresSemantic proximity Read

Standardized Comparison of Clinical, Cognitive, Genetic, Neuroimaging, and Fluid Biomarkers for Predicting 24-Month Progression from Mild Cognitive Impairment to Alzheimer’s DiseaseSemantic proximity Read

Multimodal Integration of Alzheimer's Plasma Biomarkers, MRI, and Genetic Risk for Individual Prediction of Cerebral Amyloid BurdenSemantic proximity Read

Multimodal axes reveal individualized amyloid-β, tau, and neurodegeneration coupling in aging and Alzheimer’s diseaseSemantic proximity Read

Plasma p-tau217 predicts cognitive impairments up to ten years before onset in normal older adultsSemantic proximity Read

Plasma biomarker levels and cognitive decline in a heterogenous community-based cohort with multiple comorbiditiesSemantic proximity Read

Identification of a simple and novel cut-point based CSF and MRI signature for predicting Alzheimer’s disease progression that reinforces the 2018 NIA-AA research frameworkSemantic proximity Read

Clinical and Pathological Progression of Awareness Trajectories in Preclinical Alzheimer’s DiseaseSemantic proximity Read

Computational Risk Stratification of Preclinical Alzheimer’s in Younger AdultsSemantic proximity Read

Plasma biomarkers predict amyloid conversion and cognitive decline in cognitively unimpaired adultsSemantic proximity Read

Plasma p-tau217, p-tau181, and Aβ42 Predicts Amyloid PET Positivity in Cognitively Unimpaired AdultsSemantic proximity Read